Skip to content
naulon
Not checkedNot checked for notices yet.

Purinergic signalling in bone

Robin Mark Howard Rumney, Ning eWang, Ankita eAgrawal and 1 more

Frontiers in Endocrinology · 2012

doi:10.3389/fendo.2012.00116 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Purinergic signalling in bone was first proposed in the early 1990s with the observation that extracellular ATP could modulate events crucial to the normal functioning of bone cells. Since then the expression of nearly all the P2Y and P2X receptors by osteoblasts and osteoclasts has been reported, mediating multiple processes including cell proliferation, differentiation, function and death. This review will highlight the most recent developments in the field of purinergic signalling in bone, with a special emphasis on recent work resulting from the European Framework 7 funded collaboration ATPBone, as well as Arthritis Research UK and Bone Research Society supported projects.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.